We are live on ! Find out more
MWR

McAdams Wright Ragen Portfolio holdings

AUM $1.79B
1-Year Est. Return 13.95%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+13.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.79B
AUM Growth
+$175M
Cap. Flow
+$113M
Cap. Flow %
6.3%
Top 10 Hldgs %
26.63%
Holding
420
New
47
Increased
185
Reduced
114
Closed
24

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.1M
2
T icon
AT&T
T
+$12.3M
3
HSP
HOSPIRA INC
HSP
+$5.25M
4
FFIV icon
F5
FFIV
+$4.47M
5
COLM icon
Columbia Sportswear
COLM
+$4M

Sector Composition

Rank Sector Weight
1 Technology 15.35%
2 Industrials 12.85%
3 Healthcare 12.05%
4 Energy 11.03%
5 Real Estate 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGSB icon
76
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$5.55M 0.31%
105,112
-25,998
-20% -$1.37M
EXPD icon
77
Expeditors International
EXPD
$23.2B
$5.25M 0.29%
119,001
+66,155
+125% +$2.85M
VWO icon
78
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$5.22M 0.29%
121,091
-2,615
-2% -$110K
NSC icon
79
Norfolk Southern
NSC
$74.3B
$5.18M 0.29%
50,298
+4,546
+10% +$446K
AGCO icon
80
AGCO
AGCO
$8.49B
$5.18M 0.29%
92,130
+4,925
+6% +$272K
BHP icon
81
BHP
BHP
$215B
$5.11M 0.29%
88,342
-59
-0.1% -$3.47K
PBT
82
Permian Basin Royalty Trust
PBT
$1.37B
$4.92M 0.28%
345,550
+34,000
+11% +$472K
AMGN icon
83
Amgen
AMGN
$198B
$4.73M 0.26%
39,956
+5,921
+17% +$685K
F icon
84
Ford
F
$57.5B
$4.67M 0.26%
270,630
+23,277
+9% +$379K
PFE icon
85
Pfizer
PFE
$141B
$4.66M 0.26%
165,321
+20,342
+14% +$580K
PCH
86
DELISTED
PotlatchDeltic
PCH
$4.57M 0.26%
110,274
+29,015
+36% +$1.14M
GSK icon
87
GSK
GSK
$102B
$4.34M 0.24%
64,974
-8,388
-11% -$568K
AMZN icon
88
Amazon
AMZN
$2.63T
$4.29M 0.24%
263,860
+12,120
+5% +$192K
UL icon
89
Unilever
UL
$133B
$4.15M 0.23%
81,404
+4,419
+6% +$221K
ASA
90
ASA Gold and Precious Metals
ASA
$969M
$4.1M 0.23%
279,649
+2,023
+0.7% +$27.6K
EFA icon
91
iShares MSCI EAFE ETF
EFA
$77.1B
$4.07M 0.23%
59,569
+430
+0.7% +$29.5K
IMO icon
92
Imperial Oil
IMO
$60.8B
$4.02M 0.22%
76,450
NWN icon
93
Northwest Natural Holdings
NWN
$2.17B
$4.02M 0.22%
85,197
+16,563
+24% +$742K
BMY icon
94
Bristol-Myers Squibb
BMY
$124B
$3.88M 0.22%
79,976
+5,161
+7% +$254K
EXC icon
95
Exelon
EXC
$47.8B
$3.8M 0.21%
146,178
+47,746
+49% +$1.22M
SO icon
96
Southern Company
SO
$108B
$3.78M 0.21%
83,301
+4,318
+5% +$191K
GOOG icon
97
Alphabet (Google) Class C
GOOG
$4.17T
$3.74M 0.21%
129,374
+33,897
+36% +$920K
PFF icon
98
iShares Preferred and Income Securities ETF
PFF
$13.3B
$3.61M 0.2%
90,418
+65,298
+260% +$2.57M
ORCL icon
99
Oracle
ORCL
$362B
$3.6M 0.2%
88,950
-14,530
-14% -$598K
RDS.A
100
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.6M 0.2%
43,728
+3,872
+10% +$303K

Similar funds

McAdams Wright Ragen's Q2 2014 Portfolio in Review

As of Q2 2014, McAdams Wright Ragen held 420 positions worth $1.79B, up 11% from $1.61B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

McAdams Wright Ragen deployed $113M of net new capital in Q2 2014, opening 47 new positions and adding to 185 existing holdings. Its largest new stake was Telefônica Brasil: 655,619 shares worth $13.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was HOSPIRA INC, an estimated $5.25M trimmed.

  • McAdams Wright Ragen's largest Q2 2014 buy was Telefônica Brasil: 655,619 shares worth $13.4M.
  • McAdams Wright Ragen added most to EMC CORPORATION in Q2 2014, an estimated $18.5M increase.
  • McAdams Wright Ragen's biggest Q2 2014 reduction was HOSPIRA INC, cutting an estimated $5.25M.
  • McAdams Wright Ragen fully exited AbbVie in Q2 2014, selling an estimated $26.1M.
  • McAdams Wright Ragen's ten largest holdings make up 27% of its $1.79B portfolio in Q2 2014.
  • McAdams Wright Ragen opened 47 new positions and closed 24 in Q2 2014.
  • McAdams Wright Ragen's portfolio value rose 11% quarter-over-quarter to $1.79B.

Based on McAdams Wright Ragen's 13F filing for Q2 2014, filed 8 Aug 2014.